EtQ Reliance
EtQ offers enterprise quality, compliance and EHS management solutions to a variety of industries. Moreover, EtQ offers visibility and control.
EtQ offers enterprise quality, compliance and EHS management solutions to a variety of industries. Moreover, EtQ offers visibility and control. Not only does its compliance platform, EtQ Reliance, provide companies with a wide variety of modules, it also provides them with the ability to control how they interact with unique business processes. At the core of EtQ’s framework is a flexible workflow tool that enables organizations to mimic their existing processes, create new ones and automate and control their compliance ecosystem. In addition to helping companies control the process, EtQ provides visibility into the compliance process. Through enterprise reporting, searching, and dashboards, companies can uncover adverse events, make better decisions and improve compliance at both the macro and micro level. Some of the processes that EtQ helps to automate include risk management, employee training, and audit management. EtQ was founded in 1992 and has main offices located in Europe and the U.S. EtQ has been providing software solutions to a variety of markets for more than 20 years. To learn more, visit www.etq.com or blog.etq.com.
http://www.etq.com/eu/pharmtech/whitepaper-supplier-life-sciences/
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
